about
Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitisA meta-analysis of the association of exhaled carbon monoxide on asthma and allergic rhinitis.Strategies of mucosal immunotherapy for allergic diseasesEffects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammationRegulatory T cells in many flavors control asthmaUpdates in the treatment of ocular allergies.Modulation of basophils' degranulation and allergy-related enzymes by monomeric and dimeric naphthoquinones.Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanismTreatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.Protease-activated receptors and prostaglandins in inflammatory lung disease.Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production.T-cell responses induced by allergen-specific immunotherapy.Allergic conjunctivitis: a comprehensive review of the literature.Allergen immunotherapy, routes of administration and cytokine networks: an update.Advances in synthetic peptide immuno-regulatory epitopes.Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patientsLocal Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.Principles of Vaccination.Immuno-evasive tactics by schistosomes identify an effective allergy preventative.Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic persepective.Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway.
P2860
Q26799723-0C5EF27D-D03D-4584-9F5A-62FD50E986C2Q33525934-53521DC9-7304-46B8-8219-ACCDC0AFAC18Q33577679-6512D89F-A937-4404-A9CF-5B834B3BAFE3Q34124817-257A4DFD-E387-4E8D-A2E8-15C68C979BDBQ34574231-D9FB2316-44CB-41CD-BC04-6A698932B273Q34620159-F3AB09F1-2BDF-455C-A64D-7AD3E82E4EBBQ35108710-9437A096-75F4-4BC1-A1BB-E2AAC5923EB5Q35199270-2C32DF1F-1A40-4BC0-9590-AF67441E64D5Q35204579-02069F2A-287F-43C5-8939-FED77250BF20Q35889245-AAC1F7EE-5687-4737-9247-3EB1BC4E711DQ37130834-39BD215F-1CBE-4DC3-8F42-D884A4CDBFE9Q37447476-F92074F3-602D-45DA-A0A8-4A9F30F76BDDQ37612898-050186D6-8DC6-4B02-A8BD-B94BFE598120Q37735267-5CCCD499-E89D-4032-B732-E07DA2591D04Q38089973-784A2964-B88A-4F4D-A51A-C62F1606F688Q38245926-43B07D36-707F-4475-9765-AF3126437753Q38268100-BE944372-3986-4F02-AD7D-00686D194E3BQ39412480-912B81A9-4DA5-43FB-A09D-0EB0AB74D4B5Q40385380-67B30526-0582-4F3A-A5D9-B3AB092D9C3CQ40715837-463EDF8D-FC53-46FC-8DEB-478BEB938427Q41373939-2C700AF3-1675-4D12-97E5-D764F34B1E5CQ42665857-719E5954-5BCB-45B9-B942-C4B7EAE7D470Q50507569-67DC73E8-4463-4A08-9474-1E92C2A41415
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunomodulation of allergic disease
@en
Immunomodulation of allergic disease.
@nl
type
label
Immunomodulation of allergic disease
@en
Immunomodulation of allergic disease.
@nl
prefLabel
Immunomodulation of allergic disease
@en
Immunomodulation of allergic disease.
@nl
P2860
P1476
Immunomodulation of allergic disease
@en
P2093
David H Broide
P2860
P304
P356
10.1146/ANNUREV.MED.60.041807.123524
P577
2009-01-01T00:00:00Z